Dopamine agonist
Showing 1 - 25 of 2,532
Hyperprolactinemia, Prolactinoma Trial in New York (Ropinirole)
Completed
- Hyperprolactinemia
- Prolactinoma
-
New York, New YorkColumbia University Medical Center
Jul 9, 2021
Restless Legs Syndrome Trial in Beijing (Pramipexole, )
Terminated
- Restless Legs Syndrome
- Pramipexole
- placebo
-
Beijing, ChinaPeking University First Hospital
Nov 28, 2021
Impulse Control Disorder Trial in Korea, Republic of (Levodopa/Carbidopa(200mg/50mg), Dopaminergic Agonists)
Completed
- Impulse Control Disorder
- Levodopa/Carbidopa(200mg/50mg)
- Dopaminergic Agonists
-
Anyang, Korea, Republic of
- +4 more
Mar 9, 2021
Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of
Recruiting
- Diffuse Midline Glioma (DMG)
- +7 more
- ONC206
- Standard of Care Radiation Therapy
-
San Francisco, California
- +2 more
Sep 13, 2022
Imaging Dopamine D2 Agonist Binding Sites in Schizophrenia
Withdrawn
- Schizophrenia
- NPA radiotracer
- +2 more
-
New York, New YorkNYU Langone Health
May 27, 2020
Endometriosis Trial in Boston (Cabergoline, Norethindrone acetate)
Completed
- Endometriosis
- Cabergoline
- Norethindrone acetate
-
Boston, MassachusettsChildren's Hospital Boston
Jan 27, 2020
Emotions, Motivation, Reward Trial in Oxford (Pramipexole, Placebo)
Completed
- Emotions
- +3 more
- Pramipexole
- Placebo
-
Oxford, Oxfordshire, United KingdomDept of Psychiatry, University of Oxford
Mar 23, 2020
Parkinson Disease Trial in Nashville (Pramipexole, Placebo)
Recruiting
- Parkinson Disease
- Pramipexole
- Placebo
-
Nashville, TennesseeVanderbilt University Medical Center
May 2, 2022
Lactation Suppressed Trial in Stanford (Cabergoline 1 MG, Placebo)
Not yet recruiting
- Lactation Suppressed
- Cabergoline 1 MG
- Placebo
-
Stanford, CaliforniaStanford University
Sep 1, 2023
Overweight and Obesity, Eating Behavior Trial in Chapel Hill (Placebo, Bromocriptine-QR)
Completed
- Overweight and Obesity
- Eating Behavior
- Placebo
- Bromocriptine-QR
-
Chapel Hill, North CarolinaUniversity of North Carolina, Chapel Hill
Aug 12, 2022
Vigor and the LDR in Parkinson Disease
Recruiting
- Parkinson Disease
- carbidopa/levodopa, as prescribed by treating physician
-
Ann Arbor, MichiganUniversity of Michigan
Dec 1, 2022
Health Trial in Edmonton (Dopamine, Metoclopramide, Placebos)
Recruiting
- Health
- Dopamine
- +5 more
-
Edmonton, Alberta, CanadaClinical Physiology Research Laboratory
Apr 6, 2022
Fibromyalgia, Pain, Chronic, Chronic Pain, Widespread Trial in Zürich (Low dose naltrexone, Placebo, Bromocriptine Mesylate
Recruiting
- Fibromyalgia
- +2 more
- Low dose naltrexone
- +3 more
-
Zürich, SwitzerlandBalgrist Campus
Feb 20, 2022
DTx Algorithms for Personalized Parkinson's Disease Treatment
Not yet recruiting
- Parkinson Disease
- Smartwatch Garmin Vivosmart [wearable sensor]
- +2 more
-
Roma, Italy
- +2 more
Jun 13, 2023
Parkinson Disease Trial in Lille (A-dopamine, optimized oral treatment)
Recruiting
- Parkinson Disease
- A-dopamine
- optimized oral treatment
-
Lille, FranceHopital Roger Salengro, CHU Lille
Oct 11, 2022
Healthy Trial in Zürich (Psilocybin, 3,4 Methylenedioxymethamphetamine, Methylphenidate)
Recruiting
- Healthy
- Psilocybin
- +2 more
-
Zürich, SwitzerlandPsychiatrische Universitätsklinik Zürich
Oct 3, 2023
Parkinson Disease Trial in France (drug, behavioral, procedure)
Recruiting
- Parkinson Disease
- Active drug: pimavanserin 17mg (2 strength tablets)
- +9 more
-
Besançon, France
- +15 more
Jan 20, 2022
Lactation Suppressed Trial in Stanford (Cabergoline 1 MG, Placebo)
Active, not recruiting
- Lactation Suppressed
- Cabergoline 1 MG
- Placebo
-
Stanford, CaliforniaStanford University
Jul 7, 2022
Anorexia Nervosa Trial in San Diego (amisulpride, bromocriptine)
Recruiting
- Anorexia Nervosa
-
San Diego, CaliforniaUniversity of California San Diego
Sep 2, 2021
Schizophrenia, Glucose Intolerance Trial in Pittsburgh (Bromocriptine)
Not yet recruiting
- Schizophrenia
- Glucose Intolerance
-
Pittsburgh, PennsylvaniaVA Pittsburgh Healthcare System
Oct 11, 2022
Impulsivity in Idiopathic REM Sleep Behavior Disorder
Recruiting
- Parkinson Disease
- No intervention
-
Hong Kong, Hong KongThe Chinese University of Hong Kong
Aug 22, 2022
Frontotemporal Dementia, Dementia, Aphasia, Primary Progressive Trial in Brescia, Rome (Rotigotine 4Mg/24Hrs Patch, Rotigotine
Active, not recruiting
- Frontotemporal Dementia
- +19 more
- Rotigotine 4Mg/24Hrs Patch
- +2 more
-
Brescia, Italy
- +2 more
Jul 7, 2022
Parkinson Disease Trial (Conventional medication, Chinese herbal medicine treatment)
Not yet recruiting
- Parkinson Disease
- Conventional medication
- Chinese herbal medicine treatment
- (no location specified)
Aug 10, 2021